Product Development and Clinical Data Quality Management

"One Out of 10,000 drugs"

The product research, development and approval road is long, arduous, and costly, especially for pharmaceutical companies that are still reliant on manual processes and paper-based systems.  According to an ongoing study at Tufts (hyperlink --, the average cost of bringing a drug to market jumped from $231 million in 1991, to $802 million in 2001, to the current estimate of more than $1 billion.  After a product is successfully launched, the manufacturer must continue to comply with regulatory requirements to stay in business. 

Read More about the challenges pharmaceutical companies face in bringing a new drug to market, and how these challenges can be easily managed:

Read more:

Additional Articles

Adopting Technology in the Life Science Industry: Why Is It Taking So Long?